| Dr Seiichi Noda, MD | |
|
10012 Kennerly Rd, Suite 403, Saint Louis, MO 63128-2197 | |
| (314) 880-6676 | |
| (314) 842-4372 |
| Full Name | Dr Seiichi Noda |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 34 Years |
| Location | 10012 Kennerly Rd, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881690931 | NPI | - | NPPES |
| NV584 | Other | FL | FL MEDICARE |
| 110410800 | Medicaid | FL | |
| 1881690931 | Medicaid | MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Health First Home Care | Melbourne, FL | Home health agency |
| Holmes Regional Medical Center | Melbourne, FL | Hospital |
| Viera Hospital | Melbourne, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health First Medical Group Llc | 7416100672 | 713 |
News Archive
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
Having long decried the failings of the Affordable Care Act, Senate Republicans are purporting to fix one of its loopholes with their newly unveiled health plan.
A study in cocaine-addicted rats reports long-lasting increases in the number of neurons that produce orexin—a chemical messenger important for sleep and appetite—that may be at the root of the addiction.
› Verified 9 days ago
| Entity Name | Health First Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626495 PECOS PAC ID: 7416100672 Enrollment ID: O20130122000135 |
News Archive
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
Having long decried the failings of the Affordable Care Act, Senate Republicans are purporting to fix one of its loopholes with their newly unveiled health plan.
A study in cocaine-addicted rats reports long-lasting increases in the number of neurons that produce orexin—a chemical messenger important for sleep and appetite—that may be at the root of the addiction.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seiichi Noda, MD 3300 S Fiske Blvd, Rockledge, FL 32955-4306 Ph: (321) 434-3455 | Dr Seiichi Noda, MD 10012 Kennerly Rd, Suite 403, Saint Louis, MO 63128-2197 Ph: (314) 880-6676 |
News Archive
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles, and Cellectis plant sciences, a US-based subsidiary of Cellectis Group, the specialist in genome engineering, today announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
Having long decried the failings of the Affordable Care Act, Senate Republicans are purporting to fix one of its loopholes with their newly unveiled health plan.
A study in cocaine-addicted rats reports long-lasting increases in the number of neurons that produce orexin—a chemical messenger important for sleep and appetite—that may be at the root of the addiction.
› Verified 9 days ago
Michael Mauney, Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3023 N Ballas Rd Ste 150d, Saint Louis, MO 63131 Phone: 314-996-5287 Fax: 314-432-6068 | |
John Codd, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 126 Southarm Dr, Saint Louis, MO 63122 Phone: 314-822-1938 Fax: 314-698-2838 | |
Dr. George A Patterson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Div Surg Ct Adult Thoracic, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-7260 Fax: 314-362-6288 | |
Dr. William R.m. Ogle, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1035 Bellevue Ave Ste 500, Saint Louis, MO 63117 Phone: 314-647-8269 | |
Giovanni Speziali, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 10012 Kennerly Rd Ste 403, Saint Louis, MO 63128 Phone: 314-880-6676 | |
Dr. Bryan F Meyers, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Div Surg Ct Adult Thoracic, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-7260 Fax: 314-362-6288 | |
Dr. Ali M Alakhtar, MD, MSC, FRCSC Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1 Brookings Dr, Saint Louis, MO 63130 Phone: 314-935-5000 |